Showing results (81-90 of 158) with videos related to

Sort By:
Pageof 16
Journal of Hepatology|December 12, 2018
Rosuvastatin improves the FGF19 analogue NGM282-associated lipid changes in patients with non-alcoholic steatohepatitisMary E Rinella, James F Trotter, Manal F Abdelmalek, et al.
Cellular and Molecular Gastroenterology and Hepatology|December 28, 2019
Increased Glutaminolysis Marks Active Scarring in Nonalcoholic Steatohepatitis ProgressionKuo Du, Satish K Chitneni, Ayako Suzuki, et al.
Liver International : Official Journal of the International Association for the Study of the Liver|September 26, 2018
Relationship between three commonly used non-invasive fibrosis biomarkers and improvement in fibrosis stage in patients with non-alcoholic steatohepatitisNaga Chalasani, Manal F Abdelmalek, Rohit Loomba, et al.
Liver Transplantation : Official Publication of the American Association for the Study of Liver Diseases and the International Liver Transplantation Society|September 18, 2004
One-year protocol liver biopsy can stratify fibrosis progression in liver transplant recipients with recurrent hepatitis C infectionRoberto J Firpi, Manal F Abdelmalek, Consuelo Soldevila-Pico, et al.
ESC Heart Failure|February 15, 2021
Association of liver fibrosis risk scores with clinical outcomes in patients with heart failure with preserved ejection fraction: findings from TOPCATAnthony E Peters, Ambarish Pandey, Colby Ayers, et al.
Radiology|November 1, 2022
MRI Quantification of Placebo Effect in Nonalcoholic Steatohepatitis Clinical TrialsMarybeth A Nedrud, Mohammad Chaudhry, Michael S Middleton, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|March 19, 2025
Biomarkers of Histological Response in Lanifibranor-treated Patients With Metabolic Dysfunction-associated SteatohepatitisJérôme Boursier, Hugo Hervé, Marine Roux, et al.
Hepatology Communications|February 21, 2024
Alterations in zonal distribution and plasma membrane localization of hepatocyte bile acid transporters in patients with NAFLDWilliam A Murphy, Anna Mae Diehl, Matthew Shane Loop, et al.
Hepatology (Baltimore, Md.)|February 27, 2016
A longer duration of estrogen deficiency increases fibrosis risk among postmenopausal women with nonalcoholic fatty liver diseaseJagpal Singh Klair, Ju Dong Yang, Manal F Abdelmalek, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association|April 15, 2023
Cenicriviroc Lacked Efficacy to Treat Liver Fibrosis in Nonalcoholic Steatohepatitis: AURORA Phase III Randomized StudyQuentin M Anstee, Brent A Neuschwander-Tetri, Vincent Wai-Sun Wong, et al.
Pageof 16